Evidence map›Paper›PMID 42121238›Full record

ArticleOrphanet journal of rare diseases2026

Screening for acid sphingomyelinase deficiency in patients with an interstitial lung disease.

Marie Vermant, Ilse Van Raemdonck, Nathalie Veyt, Marianne S Carlon, Emanuela Elsa Cortesi, Nico De Crem, Marieke De Rooy, Tine Follet, Stefan Gogaert, Bart Vanaudenaerde and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marie VermantDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium. marie.vermant@uzleuven.be.ORCID http://orcid.org/0000-0001-8546-8638
Ilse Van RaemdonckDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Nathalie VeytDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Marianne S CarlonDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Emanuela Elsa CortesiDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Nico De CremPulmonology Department, UZ Leuven, Leuven, Belgium.
Marieke De RooyDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Tine FolletDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Stefan GogaertDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Bart VanaudenaerdeDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
David CassimanDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Laurens J De SadeleerDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Wim A WuytsDepartment of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Funding

Sanofi Genzyme SGZ202013317
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42121238
PMCPMC13169869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.